Evidence map›Paper›PMID 31871943›Full record

SynthesisBioMed research international2019

Xiyang Liu, Tingjun Wan, Sijie Dang, Dong Wang, Cen Jiang, Yue Su, Mengmeng Shen, Xuchen Tang, Xia Li, Baixue Li and 2 more

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. The Challenges of Ethical Review in Clinical Research of Traditional Chinese Medicine.Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Xiyang LiuChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID https://orcid.org/0000-0001-7898-9224
Tingjun WanChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID https://orcid.org/0000-0002-9833-410X
Sijie DangSichuan Second Hospital of Traditional Chinese Medicine, Chengdu 610041, China.ORCID https://orcid.org/0000-0001-8941-8988
Dong WangChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID https://orcid.org/0000-0002-6387-9169
Cen JiangChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID https://orcid.org/0000-0003-2690-6890
Yue SuChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID https://orcid.org/0000-0003-4922-9394
Mengmeng ShenLeshan Vocational and Technical College, Leshan 614000, China.ORCID https://orcid.org/0000-0003-2631-5126
Xuchen TangPengzhou Hospital of Traditional Chinese Medicine, Pengzhou 611930, China.ORCID https://orcid.org/0000-0001-7754-1233
Xia LiChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID https://orcid.org/0000-0003-0089-7666
Baixue LiChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID https://orcid.org/0000-0002-1459-8803
Li WenChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID https://orcid.org/0000-0002-7188-9236
Quansheng FengChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID https://orcid.org/0000-0003-3437-8987
Chengdu University of Traditional Chinese Medicine · CNHangzhou Hospital of Traditional Chinese Medicine · CNLeshan Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsTraditional Chinese medicine (TCM) has been widely applied in chronic hepatitis B (CHB) supplementary treatment in China. Kidney yang deficiency syndrome (KYDS), one of the most common TCM syndromes of CHB, is more likely to progress to liver cirrhosis or hepatocellular carcinoma than other syndromes. Polymorphisms in the human leucocyte antigen- (HLA-)

methodsWe genotyped

resultsThe proportion of patients with high HBV DNA load (≥2000 IU/ml) in the KYDS group is higher than that in the non-KYDS group (60.70% [17/28] vs. 28.30% [13/46]);

conclusionWe found an association between

Indexed as

AllelesDisease ProgressionMedicine, Chinese TraditionalAdultChinaDatabases, FactualDNA, ViralFemaleGenetic Predisposition to DiseaseGenetic VariationGenotypeHepatitis B, ChronicHLA-DQ beta-ChainsHLA-DRB1 ChainsHumansMaleDNA, ViralHLA-DQB1 antigenHLA-DQ beta-ChainsHLA-DRB1 Chains

Identifiers

PMID31871943
PMCPMC6906876
OpenAlexW2991414776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.